Competition

  • October 26, 2026

    Visa, Mastercard Face Class Actions Over Swipe Fees

    Visa and Mastercard are facing class actions potentially worth billions of pounds for allegedly charging unlawful transaction fees, the law firms bringing the claims said Monday.

  • October 26, 2026

    CMA Probes FirstCash's £232M Buy Of Financial Services Biz

    Britain's antitrust regulator said Monday that it has launched a probe into the proposed £232 million ($317 million) take-private acquisition of financial services provider Ramsdens by FirstCash, a U.S. pawnshop company.

  • October 26, 2026

    Caterpillar Attacks 'Frankenstein' Price Behind Import Duty

    Caterpillar told a tribunal on Monday that the U.K. trade authority created a "Frankenstein price" to wrongly justify a steep import duty on the construction equipment giant's Chinese-made excavators following an anti-dumping investigation.

  • October 23, 2026

    5th Circ. Weighs Iowa Bid To Toss Charles Schwab Settlement

    A Fifth Circuit panel pushed Charles Schwab to explain why it should sign off on a settlement with investors resolving claims that its 2020 merger with TD Ameritrade created a monopoly, asking Friday how an agreed upon antitrust compliance program created value.

  • October 23, 2026

    Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed

    A Texas federal judge has denied Strive Specialties Inc.'s bid to undo her judgment dismissing the compounding pharmacy's lawsuit that accuses Eli Lilly and Novo Nordisk of blocking competition for GLP-1 medications, saying Strive's claim that the court committed a manifest legal error was based on the company's own misunderstanding.

  • October 23, 2026

    Roark-Owned Co. Unlawfully Uses Noncompetes, Suit Says

    Thirteen former employees of Ground Penetrating Radar Systems LLC filed a lawsuit in Ohio federal court alleging that the environmental services provider uses restrictive postemployment covenants to lock workers into low-paying jobs, stifle competition and increase its value to its investor owners, including private equity giant Roark Capital Management LLC.

  • October 23, 2026

    Dutch Software Co. Seeks To Unravel $400K Contempt Order

    A Dutch software company is looking to undo a $400,000 sanctions order against it in a long-running trademark battle with its former U.S. partner, saying there is no evidence of harm to the opposing party sufficient to support the court's contempt ruling.

  • October 23, 2026

    Generics MDL Judge Won't Extend Pause Over Conflict

    A Pennsylvania federal judge refused Friday to extend a pause on the generic-drug price-fixing multidistrict litigation, eyeing setting a new trial date for the first bellwether case initially paused by a conflict with a special master that the drugmakers say now covers "the entire MDL."

  • October 23, 2026

    NYSE Owner's $6B MarketAxess Deal Clears US Review

    Federal antitrust enforcers have ended their investigation of Intercontinental Exchange's planned $6 billion acquisition of fixed income trading platform MarketAxess Holdings Inc. after the companies gave enforcers more time to review the transaction.

  • October 23, 2026

    SEC Fights LSU Claim That Case Citations Were 'Hallucinated'

    The Southeastern Conference is disputing claims that it submitted "hallucinated" case citations in its lawsuit challenging Louisiana State University's efforts to add former professional players to its sports teams, urging an Alabama federal judge to strike the allegations.

  • October 23, 2026

    MLS Sites Sue Compass To Enforce Exclusive Listing Ban

    A group of six regional multiple listing services covering eight states sued brokerage giant Compass in New York federal court, claiming the company has threatened antitrust litigation to avoid rules set by MLS platforms that would stop Compass from withholding exclusive property listings.

  • October 23, 2026

    Lawmaker Report Targets 'Pay-To-Play' Antitrust Enforcement

    A new report from Democratic lawmakers found that influence from the White House appears to be resulting in lax antitrust enforcement and higher consumer prices, citing a number of recent settlements, case dismissals and merger decisions.

  • October 23, 2026

    Burford Affiliate Fights For Stay In Suit Over Alleged Fraud

    A German Burford Capital affiliate is pressing a Delaware federal court to keep on hold a German claims aggregator's lawsuit over an allegedly fraudulent arbitration agreement, disputing the latter company's argument that a London tribunal has confirmed that the matter belongs in court.

  • October 23, 2026

    Verisk Must Pursue $2.35B AccuLynx Deal, Del. Court Says

    The Delaware Supreme Court on Friday upheld a ruling that Verisk Analytics Inc. improperly abandoned its $2.35 billion acquisition of roofing software company AccuLynx, leaving the data analytics company obligated to keep pursuing federal antitrust clearance and close the deal if regulators approve it.

  • October 23, 2026

    Economy Top Of Mind As M&A Optimism Falls, Survey Shows

    A new survey from Dykema Gossett PLLC found that roughly half of dealmakers expect U.S. mergers and acquisitions activity to increase over the next 12 months, down from 74% last year, but there is notable enthusiasm about the middle market strengthening and artificial intelligence speeding up deal processes.

  • October 23, 2026

    NASCAR Team Fights Rival's Inspection Bid In Secrets Row

    NASCAR powerhouse Joe Gibbs Racing is pushing a North Carolina federal judge to deny a rival team's bid to inspect its premises as part of a simmering trade secrets dispute, emphasizing the competitive threat posed by the request.

  • October 22, 2026

    Syngenta's Pesticide Rebates To Face FTC Antitrust Trial

    Syngenta cannot escape the Federal Trade Commission's allegations it uses a loyalty rebate program to block competition from rival generic pesticides, a North Carolina federal judge ruled Thursday, saying it will be up to a jury to iron out whether the rebates are unlawful exclusive dealing.

  • October 22, 2026

    States Ask DC Circ. To Ban Google From Paying To Be Default

    If the D.C. Circuit doesn't ban Google from paying to be the default search engine on people's cellphones after it was found to have illegally maintained a monopoly, state enforcers say the tech titan will remain "free to buy tomorrow's defaults with the fruits of yesterday's anticompetitive conduct."

  • October 22, 2026

    Trump, World Liberty Sued Over 'Corrupt' $2B UAE Deal

    A former employee of stablecoin issuer Circle sued President Donald Trump and the Trump-tied crypto firm World Liberty Financial Thursday over allegedly "corrupt" business deals with the United Arab Emirates that the software engineer says violated the Constitution and harmed his former employer.

  • October 22, 2026

    Live Nation Details Woodward, Trump Role In DOJ Deal

    Live Nation Entertainment Inc. has offered new details on the involvement of the White House and senior Justice Department officials in its controversial midtrial settlement Democrats have cast as corrupt, confirming that Associate Attorney General Stanley E. Woodward Jr.'s office was also involved.

  • October 22, 2026

    Paramount Gets Viewers' Deal Challenge Tossed Again

    A California federal court has tossed a case from consumers challenging Paramount's merger with Skydance and completed purchase of Warner Bros. Discovery, finding for a second time that the case fails to properly allege any harm from the deals.

  • October 22, 2026

    Full 9th Circ. Won't Review Surgical Robot Antitrust Fight

    The full Ninth Circuit declined to reconsider an appellate panel's recent decision reviving a surgical repair company's antitrust suit alleging Intuitive Surgical blocked third parties from supplying parts for its popular da Vinci surgery robot, according to an order issued Thursday.

  • October 22, 2026

    Mylan Settles Connecticut's EpiPen Price Claims For $8M

    Mylan Pharmaceuticals has struck another deal to resolve claims that it illegally inflated prices for EpiPens, this time settling Connecticut state enforcers' allegations of antitrust and consumer protection law violations for $8 million.

  • October 22, 2026

    FTC's Meador Questions 'Reliance' On Hovenkamp Treatise

    Federal Trade Commission member Mark Meador vouched Thursday for an "aggregation" theory of antitrust violations that can combine conduct that may not be anticompetitive individually, in a Houston speech that also took direct aim at a foundational academic treatise of modern competition law.

  • October 22, 2026

    Judge Says BCBS' Evidence Ask In Ford Case Too Late

    A Michigan federal judge on Thursday denied Blue Cross Blue Shield of Michigan's motion to compel Ford Motor Company to produce emails from a senior director, ruling that the health insurer waited too long to make the request in the antitrust suit.

Expert Analysis

  • Series

    Teaching SEC Investigations Makes Me A Better Lawyer

    Author Photo

    Instructing a law school course on U.S. Securities and Exchange Commission investigations has made me a more thoughtful, deliberate practitioner because it requires me to continually reassess and challenge what I know about securities law enforcement, how I know it and how best to explain it, says David Chase at Miami Law.

  • Noncompete Laws Show States Focusing On Bans, Healthcare

    Author Photo

    The first half of 2026 confirms that state legislatures are driving the most consequential changes in noncompete law, including a few state bans and several healthcare-specific laws, making a one-size-fits-all approach increasingly untenable for multistate employers, say attorneys at Faegre Drinker.

  • And Now A Word From The Panel: MDL Judge Selection

    Author Photo

    To understand how the Judicial Panel on Multidistrict Litigation selects particular judges to preside over MDL proceedings, it helps to consider not only how much experience on the federal bench a judge has, but also whether they have specifically managed any prior MDLs, says Alan Rothman at Sidley Austin.

  • Assessing DOJ Antitrust's New, Faster Merger Review Option

    Author Photo

    The U.S. Justice Department Antitrust Division's recently announced targeted second request option and new model timing signal a commercially friendly stance and a departure from the prior administration's position, say attorneys at Paul Weiss.

  • Series

    Judges On AI: Examining Administrative, Organizational Uses

    Author Photo

    U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.

  • AG Watch: Ohio AG Joins State Antitrust Enforcement Trend

    Author Photo

    Amid the recent reprioritization in the federal government's competition enforcement agenda, two recent cases provide critical insight into how the Ohio attorney general will proceed in the relatively unprecedented trend of state attorneys general aggressively pursuing antitrust matters, say attorneys at BakerHostetler.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

  • Parsing Who Gets The Track Record In A Venture Partner Split

    Author Photo

    A recent California federal court order in TEEC Angel Management v. Tsingyuan Ventures allowing Lanham Act claims to proceed confirms that the question of who gets to tell the story of a shared win is now being litigated as false advertising instead of industry professional etiquette, says Ben Dubin at VC Expert Services.

  • Trade Secret Practice Tips From The 1st Half Of 2026

    Author Photo

    Intellectual property attorneys should consider what several significant developments in 2026 thus far mean for how they protect, litigate and value trade secrets, focusing on new state noncompete bans, cases scrutinizing how plaintiffs identify trade secrets and federal rulings on damages doctrines, say attorneys at Faegre Drinker.

  • High Court Rulings Could Alter Agency Strategy For Cos.

    Author Photo

    The U.S. Supreme Court's recent decisions in Trump v. Slaughter and Trump v. Cook mark major turning points in the law of independent agencies and in how regulated companies should think about federal enforcement, rulemaking and agency-facing strategy, say attorneys at Holtzman Vogel.

  • Quantifying Damages In Product Launch Delay Allegations

    Author Photo

    In delayed generic-drug entry cases that have generated substantial settlements in recent years, damages are often measured by profits lost during the delay window, but this model can fail to account for potentially significant economic harm that occurs after that window, say analysts at Kroll.

  • 2 Microsoft Matters Could Help Shape AI Antitrust Outlook

    Author Photo

    A pending federal court case and investigation focusing on Microsoft's allegedly anticompetitive conduct in the deployment of artificial intelligence tools are testing whether antitrust law can distinguish ordinary competition to supply the AI ecosystem from conduct that distorts how that competition unfolds, says Kylie Kim at Massey & Gail.

  • Carbon Health Settlement Highlights Why Evidence Is Key

    Author Photo

    The California Attorney General's Office's first-of-its-kind settlement with Carbon Health, imposing penalties for alleged corporate practice of medicine violations, shows that friendly professional corporation challenges usually hinge not on the parties' management services agreement, but on whether the operational record matches it, says Ben Dubin at VC Expert Services.

  • Fed Autonomy Rests On Narrow Exception After Justices Rule

    Author Photo

    The U.S. Supreme Court’s recent decisions in Trump v. Cook and Trump v. Slaughter expand presidential removal power while temporarily preserving the Federal Reserve’s independence, but there is uncertainty about which of the Fed’s authorities fall within the court’s narrow monetary-policy exception, says Keith Bradley at Squire Patton.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.